Tests, measures, and samples | Clinic or laboratory | Baseline | Day 2 | 30 days | 52 weeks |
---|---|---|---|---|---|
Sputum sample | Clinic | × | × | × | |
Blood sample (some study sites) | Clinic | × | |||
Screening interview | Clinic | × | |||
Enrollment interview | Clinic | × | |||
Enrollment chart review | Clinic | × | |||
Day-2 specimen collection | Clinic | × | |||
30-day chart review | Clinic | × | |||
52-week interview | Clinic | × | |||
52-week chart review | Clinic | × | |||
Sample collection | Laboratory | × | × | ||
Sample processing | Laboratory | × | × | ||
Smear microscopy | Laboratory | × | × | ||
Mycobacterial growth indicator tube culture | Laboratory | × | × | ||
Presumptive identification | Laboratory | × | × | ||
Confirmatory identification | Laboratory | × | × | ||
Löwenstein-Jensen culture | Laboratory | × | × | ||
Mycobacterial growth indicator tube drug susceptibility test | Laboratory | × | × | ||
Hain GenoType®MTBDRplus | Laboratory | × | |||
Hain GenoType®MTBDRsl | Laboratory | × | |||
Microscopic observation drug susceptibility assay | Laboratory | × | |||
Pyrosequencing | Laboratory | × | |||
Freezing and storage | Laboratory | × | × |